(Q39437633)

12 September 2017

1 reference

title

Current perspectives on multidrug-resistant bacteria. Epidemiology and control (English)

1 reference

12 September 2017

main subject

multiple drug resistance

1 reference

Segal-Maurer S

1

1 reference

12 September 2017

Urban C

series ordinal

2

1 reference

12 September 2017

Rahal JJ Jr

series ordinal

3

1 reference

12 September 2017

publication date

1 December 1996

1 reference

Infectious Disease Clinics of North America

12 September 2017

published in

1 reference

12 September 2017

volume

10

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

939-957

1 reference

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Control of Tuberculosis -- The Law and the Public's Health

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Genetics and mechanisms of glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Tuberculosis: commentary on a reemergent killer

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Controlling vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Emergence of drug-resistant pneumococcal infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Bacille Calmette-Guérin vaccination for the prevention of tuberculosis in health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Tuberculosis in New York City--turning the tide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Communicating about risk of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Bacteremia due to vancomycin-dependent Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

The tuberculin skin test

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Genetics of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Prevalence and resistance mechanisms of common bacterial respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Pneumococcal conjugate vaccines: review and update

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Antibiotic-resistant pneumococci in pediatric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Nosocomial tuberculosis: new progress in control and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Natural history of colonization with vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Methicillin-resistant Staphylococcus aureus as a community organism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Fixed-dose combinations of antituberculous medications to prevent drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Frequent acquisition of multiple strains of methicillin-resistant Staphylococcus aureus by healthcare workers in an endemic hospital environment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Predictors and outcome of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Major trends in the microbial etiology of nosocomial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Environmental control of tuberculosis: continuing controversy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

AIDS, tuberculosis, and the health care worker

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Household transmission of vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Secondary prophylaxis for tuberculosis in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Infections Caused by Staphylococcus aureus in a Veterans' Affairs Nursing Home Care Unit: A 5-Year Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Antimicrobial resistance in long-term-care facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Development of a standardized screening method for detection of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Improved outcomes for patients with multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

A citywide survey of vancomycin-resistant Enterococcus--New York City, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970334-2

7 January 2021

10.1016/S0891-5520(05)70334-2

Identifiers

DOI

1 reference

12 September 2017

1 reference